Skip to main content
. 2019 Nov 18;91(1):9–14. doi: 10.1136/jnnp-2019-321653

Figure 1.

Figure 1

An overview of recent treatment trials in optic neuritis (updated from figure 1 in (25)). Eculizumab has been approved by the Food and Drug Administration for treatment of ON in neuromyelitis optica spectrum disease in July 2019. ON, optic neuritis.